Drugs / aspart 30
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02467920 Comparator | Aug 2015 → Dec 2017 | type 2 diabetes mellitus | Huazhong University of Science and Technology | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | aspart 30 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02467920 ↗ |
| Route | Subcutaneous | “subcutaneous injection, twice daily” NCT02467920 ↗ |